Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development

Paola Di Bonito,1 Linda Petrone,1 Gabriele Casini,2 Iolanda Francolini,2 Maria Grazia Ammendolia,3 Luisa Accardi,1 Antonella Piozzi,2 Lucio D’Ilario,2 Andrea Martinelli2 1Department of Infectious, Parasitic and Immune-mediated Diseases, Italian National Institute of Health, 2Department of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Di Bonito P, Petrone L, Casini G, Francolini I, Ammendolia MG, Accardi L, Piozzi A, D’Ilario L, Martinelli A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/4d752099be5248b1822f850eb5efd594
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4d752099be5248b1822f850eb5efd594
record_format dspace
spelling oai:doaj.org-article:4d752099be5248b1822f850eb5efd5942021-12-02T01:04:59ZAmino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development1178-2013https://doaj.org/article/4d752099be5248b1822f850eb5efd5942015-05-01T00:00:00Zhttp://www.dovepress.com/amino-functionalized-polyl-lactide-lamellar-single-crystals-as-a-valua-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Paola Di Bonito,1 Linda Petrone,1 Gabriele Casini,2 Iolanda Francolini,2 Maria Grazia Ammendolia,3 Luisa Accardi,1 Antonella Piozzi,2 Lucio D’Ilario,2 Andrea Martinelli2 1Department of Infectious, Parasitic and Immune-mediated Diseases, Italian National Institute of Health, 2Department of Chemistry, Sapienza University of Rome, Rome, Italy; 3Department of Technology and Health, Italian National Institute of Health, Rome, Italy Background: Poly(L-lactide) (PLLA) is a biodegradable polymer currently used in many biomedical applications, including the production of resorbable surgical devices, porous scaffolds for tissue engineering, nanoparticles and microparticles for the controlled release of drugs or antigens. The surfaces of lamellar PLLA single crystals (PLLAsc) were provided with amino groups by reaction with a multifunctional amine and used to adsorb an Escherichia coli-produced human papillomavirus (HPV)16-E7 protein to evaluate its possible use in antigen delivery for vaccine development.Methods: PLLA single crystals were made to react with tetraethylenepentamine to obtain amino-functionalized PLLA single crystals (APLLAsc). Pristine and amino-functionalized PLLAsc showed a two-dimensional microsized and one-dimensional nanosized lamellar morphology, with a lateral dimension of about 15–20 µm, a thickness of about 12 nm, and a surface specific area of about 130 m2/g. Both particles were characterized and loaded with HPV16-E7 before being administered to C57BL/6 mice for immunogenicity studies. The E7-specific humoral-mediated and cell-mediated immune response as well as tumor protective immunity were analyzed in mice challenged with TC-1 cancer cells.Results: Pristine and amino-functionalized PLLAsc adsorbed similar amounts of E7 protein, but in protein-release experiments E7-PLLAsc released a higher amount of protein than E7-APLLAsc. When the complexes were dried for observation by scanning electron microscopy, both samples showed a compact layer, but E7-APLLAsc showed greater roughness than E7-PLLAsc. Immunization experiments in mice showed that E7-APLLAsc induced a stronger E7-specific immune response when compared with E7-PLLAsc. Immunoglobulin G isotyping and interferon gamma analysis suggested a mixed Th1/Th2 immune response in both E7-PLLAsc-immunized and E7-APLLAsc-immunized mice. However, only the mice receiving E7-APLLAsc were fully protected from TC-1 tumor growth after three doses of vaccine.Conclusion: Our results show that APLLA single crystals improve the immunogenicity of HPV16-E7 and indicate that E7-APLLAsc could be used for development of an HPV16 therapeutic vaccine against HPV16-related tumors. Keywords: poly(L-lactide), lamellar crystals, human papillomavirus, HPV16-E7, therapeutic vaccineDi Bonito PPetrone LCasini GFrancolini IAmmendolia MGAccardi LPiozzi AD’Ilario LMartinelli ADove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 3447-3458 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Di Bonito P
Petrone L
Casini G
Francolini I
Ammendolia MG
Accardi L
Piozzi A
D’Ilario L
Martinelli A
Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
description Paola Di Bonito,1 Linda Petrone,1 Gabriele Casini,2 Iolanda Francolini,2 Maria Grazia Ammendolia,3 Luisa Accardi,1 Antonella Piozzi,2 Lucio D’Ilario,2 Andrea Martinelli2 1Department of Infectious, Parasitic and Immune-mediated Diseases, Italian National Institute of Health, 2Department of Chemistry, Sapienza University of Rome, Rome, Italy; 3Department of Technology and Health, Italian National Institute of Health, Rome, Italy Background: Poly(L-lactide) (PLLA) is a biodegradable polymer currently used in many biomedical applications, including the production of resorbable surgical devices, porous scaffolds for tissue engineering, nanoparticles and microparticles for the controlled release of drugs or antigens. The surfaces of lamellar PLLA single crystals (PLLAsc) were provided with amino groups by reaction with a multifunctional amine and used to adsorb an Escherichia coli-produced human papillomavirus (HPV)16-E7 protein to evaluate its possible use in antigen delivery for vaccine development.Methods: PLLA single crystals were made to react with tetraethylenepentamine to obtain amino-functionalized PLLA single crystals (APLLAsc). Pristine and amino-functionalized PLLAsc showed a two-dimensional microsized and one-dimensional nanosized lamellar morphology, with a lateral dimension of about 15–20 µm, a thickness of about 12 nm, and a surface specific area of about 130 m2/g. Both particles were characterized and loaded with HPV16-E7 before being administered to C57BL/6 mice for immunogenicity studies. The E7-specific humoral-mediated and cell-mediated immune response as well as tumor protective immunity were analyzed in mice challenged with TC-1 cancer cells.Results: Pristine and amino-functionalized PLLAsc adsorbed similar amounts of E7 protein, but in protein-release experiments E7-PLLAsc released a higher amount of protein than E7-APLLAsc. When the complexes were dried for observation by scanning electron microscopy, both samples showed a compact layer, but E7-APLLAsc showed greater roughness than E7-PLLAsc. Immunization experiments in mice showed that E7-APLLAsc induced a stronger E7-specific immune response when compared with E7-PLLAsc. Immunoglobulin G isotyping and interferon gamma analysis suggested a mixed Th1/Th2 immune response in both E7-PLLAsc-immunized and E7-APLLAsc-immunized mice. However, only the mice receiving E7-APLLAsc were fully protected from TC-1 tumor growth after three doses of vaccine.Conclusion: Our results show that APLLA single crystals improve the immunogenicity of HPV16-E7 and indicate that E7-APLLAsc could be used for development of an HPV16 therapeutic vaccine against HPV16-related tumors. Keywords: poly(L-lactide), lamellar crystals, human papillomavirus, HPV16-E7, therapeutic vaccine
format article
author Di Bonito P
Petrone L
Casini G
Francolini I
Ammendolia MG
Accardi L
Piozzi A
D’Ilario L
Martinelli A
author_facet Di Bonito P
Petrone L
Casini G
Francolini I
Ammendolia MG
Accardi L
Piozzi A
D’Ilario L
Martinelli A
author_sort Di Bonito P
title Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
title_short Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
title_full Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
title_fullStr Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
title_full_unstemmed Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development
title_sort amino-functionalized poly(l-lactide) lamellar single crystals as a valuable substrate for delivery of hpv16-e7 tumor antigen in vaccine development
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/4d752099be5248b1822f850eb5efd594
work_keys_str_mv AT dibonitop aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT petronel aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT casinig aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT francolinii aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT ammendoliamg aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT accardil aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT piozzia aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT dilariol aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
AT martinellia aminofunctionalizedpolyllactidelamellarsinglecrystalsasavaluablesubstratefordeliveryofhpv16e7tumorantigeninvaccinedevelopment
_version_ 1718403314350030848